Anixa Biosciences Inc (ANIX)
3.57
+0.10
(+2.88%)
USD |
NASDAQ |
Nov 05, 16:00
3.57
0.00 (0.00%)
After-Hours: 18:20
Anixa Biosciences Price to Book Value: 5.277 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 5.129 |
| November 01, 2024 | 5.410 |
| October 31, 2024 | 5.173 |
| October 30, 2024 | 5.306 |
| October 29, 2024 | 5.838 |
| October 28, 2024 | 5.868 |
| October 25, 2024 | 4.804 |
| October 24, 2024 | 4.656 |
| October 23, 2024 | 4.671 |
| October 22, 2024 | 4.479 |
| October 21, 2024 | 4.523 |
| October 18, 2024 | 4.449 |
| October 17, 2024 | 4.420 |
| October 16, 2024 | 4.523 |
| October 15, 2024 | 4.479 |
| October 14, 2024 | 4.508 |
| October 11, 2024 | 4.449 |
| October 10, 2024 | 4.449 |
| October 09, 2024 | 4.523 |
| October 08, 2024 | 4.552 |
| October 07, 2024 | 4.626 |
| October 04, 2024 | 4.656 |
| October 03, 2024 | 4.656 |
| October 02, 2024 | 4.671 |
| October 01, 2024 | 4.656 |
| Date | Value |
|---|---|
| September 30, 2024 | 4.656 |
| September 27, 2024 | 4.715 |
| September 26, 2024 | 4.700 |
| September 25, 2024 | 4.656 |
| September 24, 2024 | 4.996 |
| September 23, 2024 | 4.774 |
| September 20, 2024 | 5.144 |
| September 19, 2024 | 5.055 |
| September 18, 2024 | 5.099 |
| September 17, 2024 | 5.085 |
| September 16, 2024 | 4.878 |
| September 13, 2024 | 4.952 |
| September 12, 2024 | 4.907 |
| September 11, 2024 | 4.567 |
| September 10, 2024 | 4.597 |
| September 09, 2024 | 4.686 |
| September 06, 2024 | 4.745 |
| September 05, 2024 | 4.961 |
| September 04, 2024 | 5.124 |
| September 03, 2024 | 4.769 |
| August 30, 2024 | 4.932 |
| August 29, 2024 | 4.902 |
| August 28, 2024 | 4.858 |
| August 27, 2024 | 4.946 |
| August 26, 2024 | 4.991 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.220
Minimum
Mar 15 2022
16.15
Maximum
Jan 22 2020
5.726
Average
4.540
Median
Mar 17 2023
Price to Book Value Benchmarks
| Annovis Bio Inc | -- |
| Akero Therapeutics Inc | 2.842 |
| ACADIA Pharmaceuticals Inc | 4.819 |
| Amicus Therapeutics Inc | 26.30 |
| Intra-Cellular Therapies Inc | 8.271 |
Price to Book Value Related Metrics
| Price | 3.57 |
| Earnings Yield | -10.92% |
| Market Cap | 114.88M |